The pathophysiology of pre-eclampsia: Current clinical concepts

References

• ACOG Committee on Practice Bulletins–Obstetrics. ACOG practice bulletin: Diagnosis and management of preeclampsia and eclampsia. Obstetrics and Gynecology 2002; 99: 159
   PubMed Web of Science ®Google Scholar
• Barton J, Sibai B. Prediction and prevention of recurrent preeclampsia. Obstetrics and Gynecology 2008; 112: 359–372
   PubMed Web of Science ®Google Scholar
• Chaouat G, Ledee-Bataille N, Dubanchet S. Immune cells in uteroplacental tissues throughout pregnancy: a brief review. Reproductive BioMedicine Online 2006; 14: 256–266
   Web of Science ®Google Scholar
• Cines D, Pollak E, Buck C, Loscalzo J, Zimmerman G, McEver R, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527–3561
   PubMed Web of Science ®Google Scholar
• Clark J, Niles J. Abdominal pregnancy associated with toxemia of pregnancy. Journal of the National Medical Association 1967; 59: 22–24
   PubMedGoogle Scholar
• Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: Systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 2008; 198: 7–22
   PubMed Web of Science ®Google Scholar
• Cunningham F G, Lindheimer M D. Hypertension in pregnancy. New England Journal of Medicine 1992; 326: 927–932
   PubMed Web of Science ®Google Scholar
• Egleton R, Brown K, Dasgupta P. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases. Pharmacology and Therapeutics 2009; 121: 205–223
   PubMed Web of Science ®Google Scholar
• Esplin M, Fausett M, Fraser A, Kerber R, Mineau G, Carrillo J, et al. Paternal and maternal components of the predisposition to preeclampsia. New England Journal of Medicine 2001; 344: 867
   PubMed Web of Science ®Google Scholar
• Goldman-Whol D, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Molecular Human Reproduction 2000; 6: 88–95
   PubMed Web of Science ®Google Scholar
• Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S. Decidual cells regulate key developmental processes at the human fetal-maternal interface. Nature Medicine 2006; 12: 1065–1074
   PubMed Web of Science ®Google Scholar
• Harkskamp R, Zeeman G. Preeclampsia: at risk for remote cardiovascular disease. American Journal of the Medical Sciences 2007; 334: 291–295
   PubMed Web of Science ®Google Scholar
• Hiby S, Walker J, O'Shaughnessy K, Redman C, Carrington M, Trowsdale J, et al. Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success. Journal of Experimental Medicine 2004; 200: 957–965
   PubMed Web of Science ®Google Scholar
• Hiby S, Regan L, Farrell L, Carrington M, Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Human Reproduction 2008; 23: 972–976
   PubMed Web of Science ®Google Scholar
• Kopcow H, Karumanchi A. Angiogenic factors and natural killer (NK) cells in the pathogenesis of preeclampsia. Journal of Reproductive Immunology 2007; 76: 23–29
   PubMed Web of Science ®Google Scholar
• Kwak-Kim J, Gilman-Sachs A. Clinical implication of natural killer cells and reproduction. American Journal of Reproductive Immunology 2008; 59: 388–400
   PubMed Web of Science ®Google Scholar
• Le Bouteiller P, Pizzato N, Barakonyi A, Solier C. HLA-G, pre-eclampsia, immunity and vascular events. Journal of Reproductive Immunology 2003; 59: 219–234
   PubMed Web of Science ®Google Scholar
• LaMarca B, Gilbert J, Granger J. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 2008; 51: 982–988
   PubMed Web of Science ®Google Scholar
• Levine R J, Lam C, Qian C, Yu K F, Maynard S E, Sachs B P, , for the CPEP Study Group, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. Obstetrical and Gynecological Survey 2007; 62: 82–83
   Google Scholar
• MMWR. Maternal mortality – United States, 1982–1996. Morbidity and Mortality Weekly Report 1998; 47: 705–707
   PubMedGoogle Scholar
• Maynard S E, Venkatesha S, Thadhani R, Karumanchi S A. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatric Research 2005; 57: 1R–7R
   PubMed Web of Science ®Google Scholar
• Miko E, Szereday L, Barakonyi A, Jarkovich A, Varga P, Szekeres-Bartho J. The role of invariant NKT cells in pre-eclampsia. American Journal of Reproductive Immunology 2008; 60: 118–126
   PubMed Web of Science ®Google Scholar
• Moffet A, Hiby S. How dose the maternal immune system contribute to the development of pre-eclampsia?. Placenta 2007; 28: S51–S56
   PubMed Web of Science ®Google Scholar
• Mogren I, Högberg U, Winkvist A, Stenlund H. Familial occurrence of preeclampsia. Epidemiology 1999; 10: 518–522
   PubMed Web of Science ®Google Scholar
• Pfarrer C, Macara L, Leiser R, Kingdom J. Adaptive angiogenesis in placentas of heavy smokers. The Lancet 1999; 354: 303
   PubMed Web of Science ®Google Scholar
• Rana S, Karumanchi S A, Levine R J, Venkatesha S, Rauh-Hain J A, Tamez H, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007; 50: 137–142
   PubMed Web of Science ®Google Scholar
• Redman C, Sargent I. Latest advances in understanding preeclampsia. Science 2005; 308: 1592–1594
   PubMed Web of Science ®Google Scholar
• Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. American Journal of Obstetrics and Gynecology 2000; 183: S1–S22
   PubMed Web of Science ®Google Scholar
• Robillard P, Dekker G, Chaouat G, Hulsey T. Etiology of preeclampsia: maternal vascular predisposition and couple disease – mutual exclusion or complementarity?. Journal of Reproductive Immunology 2007; 76: 1–7
   PubMed Web of Science ®Google Scholar
• Saftlas A F, Olson D R, Franks A L, Atrash H K, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979–1986. American Journal of Obstetrics and Gynecology 1990; 163: 460–465
   PubMed Web of Science ®Google Scholar
• Saito S, Sakai M, Sasaki Y, Nakashima A, Shiozaki A. Inadequate tolerance induction may induce pre-eclampsia. Journal of Reproductive Immunology 2007; 76: 30–39
   PubMed Web of Science ®Google Scholar
• Sargent I, Borzychowski A, Redman C. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reproductive Biomedicine Online 2006; 13: 680–686
   PubMed Web of Science ®Google Scholar
• Sargent L, Borychowski A, Redman C. NK Cells and pre-eclampsia. Journal of Reproductive Immunology 2007; 76: 40–44
   PubMed Web of Science ®Google Scholar
• Scholl T, Leskiw M, Chen X, Sims M, Stein T. Oxidative stress, diet, and the etiology of preeclampsia. American Journal of Clinical Nutrition 2005; 81: 1390–1396
   PubMed Web of Science ®Google Scholar
• Shembrey M, Noble A. An instructive case of abdominal pregnancy. The Australian and New Zealand Journal of Obstetrics and Gynaecology 1995; 35: 220–221
   PubMed Web of Science ®Google Scholar
• Sibai B M, Gordon T, Thom E, Caritis S N, Klebanoff M, McNellis D, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. American Journal of Obstetrics and Gynecology 1995; 172: 642–648
   PubMed Web of Science ®Google Scholar
• Soundararajan R, Rao A. Trophoblast ‘pseudo-tumorigenesis’: Significance and contributory factors. Reproductive Biology and Endocrinology 2004; 2: 15
   PubMedGoogle Scholar
• South Africa Every Death Counts Writing Group. Every death counts: use of mortality audit data for decision making to save the lives of mothers, babies, and children in South Africa. Lancet 2008; 371: 1294–1304
   PubMed Web of Science ®Google Scholar
• Thadhani R, Solomon C. Preeclampsia – a glimpse into the future?. New England Journal of Medicine 2008; 359: 858–860
   PubMed Web of Science ®Google Scholar
• Vikse B, Irgens L, Leivestad T, Skjærven R, Iversen B. Preeclampsia and Risk of End-Stage Renal Disease. New England Journal of Medicine 2008; 359: 800–809
   PubMed Web of Science ®Google Scholar
• Walker J. Pre-eclampsia. Lancet 2000; 356: 1260–1265
   PubMed Web of Science ®Google Scholar
• Willems J. The etiology of preeclampsia. Obstetrics and Gynecology 1977; 50: 495
   PubMed Web of Science ®Google Scholar
• Wiessgerber T, Wolfe L, Davies G. The role of regular physical activity in preeclampsia prevention. Medicine and Science in Sports and Exercise 2004; 36: 2024–2031
   PubMed Web of Science ®Google Scholar
• Wolf M, Hubel C, Lam C, Sampson M, Ecker H, Ness R, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. Journal of Clinical Endocrinology and Metabolism 2004; 89: 6239–6243
   PubMed Web of Science ®Google Scholar